Grégory Resch

This study shows that therapeutic bacteriophages clear from the body following second-order kinetics, challenging first-order assumptions and informing dose design.

This study uses a phage endolysin to target Streptococcus salivarius in the gut, revealing niche overlap with butyrate-producing taxa and potential therapeutic benefits.

This study evaluates phage community preservation during FMT production and engraftment in patients with rCDI, finding donor phages persist in recipients.